Trial status: Active, Not Recruiting to Completed
Study Statusv48
Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT00391365 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.
Track this trialTrial status: Active, Not Recruiting to Completed
Study Statusv48
Completion date: Aug 30, 2024 to Dec 31, 2025
Study Statusv47
Study Status
Re-verified, no change to tracked fields
v46
Site details revised
Study Status, Contacts/Locationsv45
9 amendments
9 re-verifications since 2018-08-01, no change to tracked fields
v36-v44
Enrollment target: 369 to 368
Study Status, Study Designv35
Enrollment target: 368 to 369
Study Status, Study Designv34
Completion date: Aug 2018 to Aug 30, 2024
Study description expanded, about 24 words
Study Status, Oversight, Study Description, Contacts/Locationsv33
Primary completion date: Aug 2015 to Aug 1, 2015
Start date: Mar 2005 to Mar 1, 2005
Study Status, Baseline Characteristicsv32
Results first posted: Dec 21, 2016
Primary endpoints: 2 to 1; Enrollment target: 358 to 368; Completion date: Jul 2018 to Aug 2018; and 3 more
Study Status, Study Description, Study Design, Outcome Measures, Participant Flow, Baseline Characteristics, Outcome Measures (Results), Adverse Events, Limitations and Caveats, More Informationv31
Study Status, Study Description
Re-verified, no change to tracked fields
v30
Primary completion date: Jun 2016 to Aug 2015
Study Statusv29
Study Status
Re-verified, no change to tracked fields
v28
Primary completion date: Aug 2015 to Jun 2016
Study Statusv27
Primary completion date changed from estimate of Aug 2018 to Aug 2015
Completion date: Jul 2030 to Jul 2018; Study description shortened, about 42 words
Study Status, Study Description, Study Design, IPDSharingv26
Primary completion date: Jun 2015 to Aug 2018
Completion date: Jul 2022 to Jul 2030; Study description expanded, about 42 words
Study Status, Study Descriptionv25
Lead sponsor: US Department of Veterans Affairs to VA Office of Research and Development
Completion date: Sep 2015 to Jul 2022; Study description expanded, about 3 words
Study Status, Sponsor/Collaborators, Study Description, Arms and Interventionsv24
Study site revised
Study Status, Contacts/Locationsv23
Enrollment target: estimated 500 to confirmed 358
Eligibility criteria shortened, about 1 word
Study Status, Study Description, Study Design, Eligibilityv22
Primary endpoints: 1 to 2
Eligibility criteria revised; Study description expanded, about 53 words
Study Status, Study Description, Outcome Measures, Eligibility, Contacts/Locationsv21
Collaborators revised (3)
Study Status, Sponsor/Collaboratorsv20
Collaborators revised (3)
Study Status, Sponsor/Collaborators, Study Descriptionv19
2 amendments
2 re-verifications since 2013-03-06, no change to tracked fields
v17-v18
Trial status: Recruiting to Active, Not Recruiting
Eligibility criteria shortened, about 1 word; Site details revised
Study Status, Study Description, Eligibility, Contacts/Locationsv16
Primary completion date: Dec 2014 to Jun 2015
Eligibility criteria expanded, about 17 words; Site contact updated
Study Identification, Study Status, Arms and Interventions, Eligibility, Contacts/Locationsv15
Study Status
Re-verified, no change to tracked fields
v14
Primary completion date: Sep 2012 to Dec 2014
Eligibility criteria expanded, about 13 words; Secondary endpoints expanded, about 2 words; Study description shortened, about 7 words; and 1 more
Study Status, Sponsor/Collaborators, Oversight, Study Description, Outcome Measures, Eligibilityv13
Study Status
Re-verified, no change to tracked fields
v12
Enrollment target: 225 to 500
Primary completion date: Oct 2012 to Sep 2012; Completion date: Oct 2012 to Sep 2015; Study description revised; and 1 more
Study Status, Study Description, Study Design, Contacts/Locationsv11
Study description revised
Collaborators: 2 to 3
Study Status, Sponsor/Collaborators, Study Descriptionv10
Study description expanded, about 1 word
Study Status, Study Descriptionv9
Study Status
Re-verified, no change to tracked fields
v8
Site contact updated
Collaborators expanded, about 14 words
Study Status, Sponsor/Collaborators, Contacts/Locationsv7
Site contact updated
Study Status, Contacts/Locationsv6
Enrollment target: 120 to 225
Study description shortened, about 114 words
Study Status, Study Description, Study Design, Arms and Interventionsv5
2 amendments
2 re-verifications since 2008-09-05, no change to tracked fields
v3-v4
Trial status: Not Yet Recruiting to Recruiting
Enrollment target: 60 to 120; Primary completion date: Oct 2012; Eligibility criteria shortened, about 27 words; and 3 more
Study Status, Sponsor/Collaborators, Study Description, Conditions, Study Design, Arms and Interventions, Outcome Measures, Eligibility, Contacts/Locationsv2
Study First Submitted
| NCT Number | NCT00391365 |
| Lead Sponsor | VA Office of Research and Development
Collaborators: Orthopaedic Associates of Michigan (Grand Rapids, MI), Orthopedic + Fracture Specialists, Portland, OR, Minnesota Orthopedic Sports Medicine Institute Twin Cities Orthopedics (Edina, MN) |
| Conditions | Osteoarthritis |
| Enrollment | 368 participants |
| Start Date | |
| Primary Completion | (estimated) |
| Study Completion | (estimated) |
| Updated on ClinicalTrials.gov |